SCHEMBL6899367

SCHEMBL6899367

C=C1CCC2C3CCc4cc(OC(C)=O)ccc4C3CC[C@]12C

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 5/20 0.69
SMN1; SMN2 Q16637 4/20 0.69
LMNA P02545 4/20 0.69
PGR P06401 2/20 0.69
AR P10275 2/20 0.69
OPRM1 P35372 2/20 0.69
SLC6A3 Q01959 2/20 0.69
ADORA3 P0DMS8 2/20 0.69
ATM Q13315 2/20 0.69
CHRM1 P11229 1/20 0.69
TBXA2R P21731 1/20 0.69
ADRA1A P35348 1/20 0.69
CYP3A4 P08684 4/20 0.67
MAPT P10636 3/20 0.67
TP53 P04637 1/20 0.67
HSD17B1 P14061 2/20 0.60
RECQL P46063 1/20 0.60
STS P08842 6/20 0.59
ABCC4 O15439 1/20 0.59
CYP2C9 P11712 1/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6899365 1.00 ESR1 (0.69) ESR1SMN1; SMN2LMNAPGRAR
Estrone Acetate SCHEMBL603954 0.89 CYP3A4 (0.76) ESR1SMN1; SMN2LMNAPGRAR
Estrone Acetate SCHEMBL20006536 0.89 CYP3A4 (0.76) ESR1SMN1; SMN2LMNAPGRAR
Estrone Acetate SCHEMBL6241050 0.89 CYP3A4 (0.76) ESR1SMN1; SMN2LMNAPGRAR
SCHEMBL10414105 0.87 MAPT (0.58) ESR1SMN1; SMN2LMNAPGRAR
SCHEMBL17817040 0.86 ESR1 (0.66) ESR1SMN1; SMN2LMNAPGRAR
SCHEMBL12379638 0.85 SMN1; SMN2 (0.64) ESR1SMN1; SMN2LMNAPGRAR
SCHEMBL2293877 0.85 SMN1; SMN2 (0.64) ESR1SMN1; SMN2LMNAPGRAR
SCHEMBL9643701 0.85 ESR1 (0.64) ESR1SMN1; SMN2LMNAPGRAR
SCHEMBL9642919 0.85 ESR1 (0.64) ESR1SMN1; SMN2LMNAPGRAR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0891188-A4 STEROIDS AS NEUROCHEMICAL INITIATORS OF CHANGE IN HUMAN BLOOD LEVELS OF LH OR FSH PHERIN PHARM INC (US) 2004-09-01 EP disclosed
US-6352980-B1 ADMINISTERING BY SPRAYING IN NOSE PHERIN PHARMACEUTICALS, INC. 2002-03-05 US disclosed
US-6331534-B1 ADMINISTERING EFFECTIVE AMOUNT OF STEROID WITHIN NASAL PASSAGE OF INDIVIDUAL SUCH THAT IT BINDS SPECIFICALLY TO RECEPTORS ON SURFACE OF NASAL NEUROEPITHELIAL CELLS IN VOMERONASAL ORGAN PHERIN PHARMACEUTICALS, INC. 2001-12-18 US disclosed
US-6117860-A NASALLY ADMINISTERING STEROID WHICH BINDS TO A SPECIFIC NEUROEPITHELIAL RECEPTOR FOR ALLEVIATING PREMENSTRUAL TENSION AND ANXIETY PHERIN PHARMACEUTICALS, INC. (US) 2000-09-12 US disclosed
US-6066627-A ALTERING BLOOD CONCNETRATION OF LUTEINIZING HORMONE PHERIN CORPORATION (US) 2000-05-23 US disclosed
US-6057439-A EPOXYSTEROIDS PHERIN CORPORATION (US) 2000-05-02 US disclosed
EP-0783513-A4 NOVEL ESTRENES FOR INDUCING HYPOTHALAMIC EFFECTS PHERIN CORP (US) 2000-03-08 EP disclosed
US-5994568-A BIND TO NEUROEPITHELIAL RECEPTORS. PHERIN CORPORATION (US) 1999-11-30 US disclosed
US-5939570-A Estrenes for inducing hypothalamic effects PHERIN CORPORATION (US) 1999-08-17 US disclosed
US-5925774-A ESTRENE STEROIDS WHICH BIND TO NEUROEPITHELIAL RECEPTORS PHERIN CORPORATION (US) 1999-07-20 US disclosed
EP-0924219-A2 Novel estrenes for inducing hypothalamic effects PHERIN CORPORATION (US) 1999-06-23 EP disclosed
EP-0891188-A1 STEROIDS AS NEUROCHEMICAL INITIATORS OF CHANGE IN HUMAN BLOOD LEVELS OF LH OR FSH Pherin Pharmaceuticals, Inc. (US) 1999-01-20 EP disclosed
WO-1997036596-A1 STEROIDS AS NEUROCHEMICAL INITIATORS OF CHANGE IN HUMAN BLOOD LEVELS OF LH OR FSH PHERIN PHARMACEUTICALS, INC. (US) 1997-10-09 WO disclosed
EP-0783513-A1 NOVEL ESTRENES FOR INDUCING HYPOTHALAMIC EFFECTS PHERIN CORPORATION (US) 1997-07-16 EP disclosed
US-5633392-A STIMULANTS FOR AUTONOMIC NERVOUS SYSTEM; NOSE SPRAYING PHERIN CORPORATION (US) 1997-05-27 US disclosed
WO-1996010032-A1 NOVEL ESTRENES FOR INDUCING HYPOTHALAMIC EFFECTS PHERIN CORPORATION (US) 1996-04-04 WO disclosed